Literature DB >> 31229978

Acquired amegakaryocytic thrombocytopenia as a rare cause of thrombocytopenia during pregnancy.

Brittney S Zimmerman1, Bridget Marcellino1, Siraj M El Jamal2, Anne S Renteria3.   

Abstract

A rare case of acquired amegakaryocytic thrombocytopenia (AATP) in a 35-year-old woman who presented with anaemia and thrombocytopenia at 22 weeks gestation. The first diagnostic impression was of an evolving aplastic anaemia; however, the patient was simultaneously diagnosed with severe vitamin B12 deficiency in the setting of vegetarianism. Once the cyanocobalamin deficiency was corrected, a repeat bone marrow biopsy revealed an isolated depletion of megakaryocytes, which suggested the diagnosis of AATP. Supportive care was provided for her anaemia and thrombocytopenia and she delivered a healthy baby girl with a normal platelet count. The patient was subsequently started on romiplostim with steady improvement in her platelet counts. This rare AATP case presentation highlights the importance of a well-structured diagnostic approach to thrombocytopenia during pregnancy and supports the successful use of thrombopoietin agonists for the management of AATP. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (incl blood transfusion); obstetrics and gynaecology; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31229978      PMCID: PMC6606057          DOI: 10.1136/bcr-2019-230361

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Hematologic complications of pregnancy.

Authors:  Danielle M Townsley
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

2.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

3.  Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.

Authors:  David J Kuter; James B Bussel; Adrian Newland; Ross I Baker; Roger M Lyons; Jeffrey Wasser; Jean-Francois Viallard; Gail Macik; Mathias Rummel; Kun Nie; Susie Jun
Journal:  Br J Haematol       Date:  2013-02-22       Impact factor: 6.998

Review 4.  How I treat thrombocytopenia in pregnancy.

Authors:  Terry Gernsheimer; Andra H James; Roberto Stasi
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

Review 5.  Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia.

Authors:  J A King; M Y Elkhalifa; L F Latour
Journal:  South Med J       Date:  1997-01       Impact factor: 0.954

6.  Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).

Authors:  Iva Cela; Ira J Miller; Robert S Katz; Amy Rizman; Jamile M Shammo
Journal:  Clin Adv Hematol Oncol       Date:  2010-11

7.  Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.

Authors:  Douglas B Cines; Terry Gernsheimer; Jeffrey Wasser; Bertrand Godeau; Drew Provan; Roger Lyons; Ivy Altomare; Xuena Wang; Angela Lopez
Journal:  Int J Hematol       Date:  2015-07-23       Impact factor: 2.490

8.  Rapid progression of acquired amegakaryocytic thrombocytopenia to myelodysplastic syndrome: case report.

Authors:  Mehmet Ali Erkurt; Emin Kaya; Murat Baran; Ece Yitmen; Soner Şenel; İrfan Kuku; İsmet Aydoğdu
Journal:  Turk J Haematol       Date:  2005-12-05       Impact factor: 1.831

Review 9.  The Differential Diagnosis of Thrombocytopenia in Pregnancy.

Authors:  Frauke Bergmann; Werner Rath
Journal:  Dtsch Arztebl Int       Date:  2015-11-20       Impact factor: 5.594

10.  [Acquired amegacaryocytic thrombocytopenic purpura hiding acute myeloid leukemia].

Authors:  Hicham Eddou; Ali Zinebi; Abdelaziz Khalloufi; Mohammed Sina; Mehdi Mahtat; Kamal Doghmi; Mohammed Mikdame; Mohammed Karim Moudden; Mohammed El Baaj
Journal:  Pan Afr Med J       Date:  2017-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.